The angioplasty balloons market is projected to grow at a CAGR of 4.91% over the forecast period, increasing from US$2.885 billion in 2025 to US$3.602 billion by 2030.
Balloon angioplasty is a procedure used to open narrowed or blocked arteries. It is a minimally invasive surgery; the growth of the minimally invasive procedures drives the overall growth. The angioplasty balloons market is witnessing growth driven by increased cases of CVDs (cardiovascular diseases), the ageing population, and increased lifestyle-related risk factors. CVDs are the leading cause of death around the world. The favourable regulatory environment is also driving the angioplasty balloons market growth.
Moreover, the angioplasty balloons market is also witnessing innovative product developments and applications. For instance, according to Eurostat (25 EU countries), there were 1.06 million transluminal coronary angioplasty procedures conducted in 2022. The transluminal coronary angioplasty was a common form of intervention for patients treated for cardiovascular diseases in the region.
Angioplasty is used during a heart attack to open a blockage and restore blood flow. Moreover, balloon angioplasty is a minimally invasive procedure that uses a balloon to treat cardiovascular diseases. Every year, cardiovascular disease (CVD) engulfs over 20.5 million lives every year. Of these deaths, 85% are due to coronary heart diseases (e.g. heart attacks) and cerebrovascular diseases (e.g. strokes).
Further, the most common risk factors are smoking, diabetes, cholesterol, eating an unhealthy diet, or living with high blood pressure; these are mostly prevalent in low- and middle-income countries. For instance, according to World Heart Day, around 620 million people were living with heart and circulatory diseases across the world in 2023. Each year, around 60 million people across the world develop a heart or circulatory disease.
There has been an emergence in the medical world for less invasive procedures, with angioplasty emerging as one of the important modalities that fits within such a paradigm. In comparison with invasive open-heart surgery, minimally invasive procedures are said to give shorter recovery periods with less pain and fewer complications. Moreover, the intervention of angioplasty consists of threading an inflated balloon catheter through the blood vessels to reach the site of the blockage, which has made it possible for the procedure to be done under an anaesthetic.
One of the major factors propelling the angioplasty balloons market is the continuous development and performance of angioplasty balloons. Drug-coated balloons, which give medication to help avoid re-constriction of arteries after angioplasty procedures, have greatly improved outcomes for such procedures. Moreover, due to the development of special balloons, such as those for hard or calcified lesions, the applicability of angioplasty has increased among patients.
The Non-compliant (NC) balloons are stiff as they do not change size or shape with inflation pressure, unlike compliant balloon catheters. Their rigidity makes them ideal because they can develop high forces for effective dilation in calcified lesions and are also appropriate for very precise dilations, making them particularly well-suited for complex procedures requiring much accuracy. NC balloons are made from robust materials that work to resist deformation and maintain radial force during dilation. They can be considered as having limited conforming devices to the vessel wall; hence, idealized for forceful dilation scenarios.
NC angioplasty balloons are specialized balloons applied in interventional cardiology procedures. Increasing elderly populations and increased risk factors such as obesity, diabetes, and hypertension have driven the rising incidence of cardiovascular disease. The ever-rising number of patients suffering from these conditions has had a corresponding effect on the rising demand for more efficient treatments like NC balloons.
Peripheral vascular disease, also known as peripheral artery disease (PAD), is a type of circulatory disorder mainly affecting the blood supply through arteries to the leg and foot. It is primarily due to atherosclerosis by fatty plaque buildup within arteries, with consequent narrowing and health complications. If not managed, it may result in immobility and dire health issues, which continue to increase demand for angioplasty balloons in the coming years.
Further, the major market players are developing and in the process of assessing the angioplasty balloon dilatation catheter, which significantly affects the PAD application segment in the angioplasty balloons market and will probably result in favourable treatment outcomes and the overall growth of the market. For instance, in September 2023, Kossel Medtech's Sabelly® non-compliant peripheral balloon dilatation catheter was approved by the National Medical Products Administration (NMPA) for market release.
The North American market growth is due to its advanced healthcare system, strong demand for cardiovascular operations, and increasing occurrence of coronary artery disease (CAD) and peripheral artery disease (PAD), which have given impetus to the market growth of the US. Further, the surge in demand for angioplasty balloons can thus be traced in significant part to the growing aged population in the United States. Age increases the chances of having cardiovascular diseases, for instance, atherosclerosis or stenosis, which need angioplasty to clear the clogged arteries. As the ageing population has medical technology very specific for this treatment adds to the demand for such gadgets. Additionally, technological improvements have enabled the development of more advanced balloons and catheters with greater performance. These advancements, such as drug-coated balloons and cutting-edge materials, improved the effectiveness and safety of PTA operations, propelling market expansion.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Angioplasty Balloons Market Size in 2025 | US$2.885 billion |
| Angioplasty Balloons Market Size in 2030 | US$3.602 billion |
| Growth Rate | CAGR of 4.91% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Billion |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in Angioplasty Balloons Market |
|
| Customization Scope | Free report customization with purchase |